Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q3 2023 Earnings

9NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.22

-0.19

-0.17

-0.14

Details

Expected EPS

-0.17

Actual EPS

-0.14

Surprise EPS

0.03

Surprise Percent

+17.65%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.14 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.